{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:03:54Z","timestamp":1762999434388,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Japan Agency for Medical Research and Development (AMED), JapanJapan Agency for Medical Research and Development (AMED), Japan","award":["JP18fk0108044"],"award-info":[{"award-number":["JP18fk0108044"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHIJapan Society for the Promotion of Science (JSPS) KAKENHI","award":["JP25460085","JP16K09952"],"award-info":[{"award-number":["JP25460085","JP16K09952"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jiac.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:50:00Z","timestamp":1549785000000},"page":"355-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Streptococcal toxic shock syndrome caused by \u03b2-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases"],"prefix":"10.1016","volume":"25","author":[{"given":"Sadako","family":"Yoshizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-1728","authenticated-orcid":false,"given":"Tadayoshi","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichibayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-6163","authenticated-orcid":false,"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-2645","authenticated-orcid":false,"given":"Manabu","family":"Ato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.01.006_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrmicro2648","article-title":"Molecular insight into invasive group A streptococcal disease","volume":"9","author":"Cole","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4161\/viru.26400","article-title":"The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis","volume":"5","author":"Reglinski","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.jiac.2019.01.006_bib3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes","volume":"9","author":"Lappin","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.micinf.2004.06.001","article-title":"Factors determining prognosis in streptococcal toxic shock-like syndrome: results of a nationwide investigation in Japan","volume":"6","author":"Hasegawa","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jiac.2019.01.006_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3201\/eid1508.090264","article-title":"Predictors of death after severe Streptococcus pyogenes infection","volume":"15","author":"Lamagni","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.11150\/kansenshogakuzasshi1970.67.236","article-title":"[Case report of toxic shock-like syndrome due to group A streptococcal infection]","volume":"67","author":"Shimizu","year":"1993","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2019.01.006_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1017\/S0950268814001265","article-title":"Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012","volume":"143","author":"Ikebe","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2019.01.006_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7883\/yoken.63.372","article-title":"Surveillance of severe invasive group G streptococcal infections in Japan during 2002-2008","volume":"63","author":"Ikebe","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0b013e31827dea11","article-title":"Streptococcus agalactiae toxic shock-like syndrome: two case reports and Review of the literature","volume":"92","author":"Al","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jiac.2019.01.006_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/JCM.42.1.186-192.2004","article-title":"Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome","volume":"42","author":"Hashikawa","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jiac.2014.12.002","article-title":"Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013","volume":"21","author":"Ikebe","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.01.006_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccc.2013.03.012","article-title":"Toxic shock syndrome. Major advances in pathogenesis, but not treatment","volume":"29","author":"Low","year":"2013","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jiac.2019.01.006_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2019.01.006_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1099\/0022-1317-49-5-467","article-title":"Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994","volume":"49","author":"Descheemaeker","year":"2000","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/653116","article-title":"Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections","volume":"51","author":"Johansson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-94-007-0940-9_12","article-title":"The nonideal coiled coil of M protein and its multifarious functions in pathogenesis","volume":"715","author":"Ghosh","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jiac.2019.01.006_bib19","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study","volume":"19","author":"Mcmillan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2019.01.006_bib20","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D","article-title":"Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection","volume":"30","author":"Norrby-Teglund","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jiac.2019.01.006_bib21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm1202-800","article-title":"An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections","volume":"8","author":"Kotb","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2019.01.006_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/323443","article-title":"Evidence for superantigen involvement in severe group a streptococcal tissue infections","volume":"184","author":"Norrby-Teglund","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib23","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/iai.65.12.5209-5215.1997","article-title":"Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates","volume":"65","author":"Norrby-Teglund","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2019.01.006_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/jcm.34.4.953-958.1996","article-title":"Sequencing emm -specific polymerase chain reaction products for routine and accurate typing of group A Streptococci","volume":"34","author":"Beall","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.01.006_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268803001262","article-title":"Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan","volume":"132","author":"Ikebe","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2019.01.006_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jiac.2019.01.006_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1189\/jlb.0912437","article-title":"Current trends in inflammatory and immunomodulatory mediators in sepsis","volume":"93","author":"Aziz","year":"2013","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jiac.2019.01.006_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jamcollsurg.2009.05.002","article-title":"Early cytokine production risk stratifies trauma patients for multiple organ failure","volume":"209","author":"Jastrow","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jiac.2019.01.006_bib30","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A\u00a0genomic storm in critically injured humans","volume":"208","author":"Xiao","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jiac.2019.01.006_bib31","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc5783","article-title":"Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis","volume":"11","author":"Bozza","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2019.01.006_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cyto.2011.12.002","article-title":"A\u00a0combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis","volume":"57","author":"Andaluz-Ojeda","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jiac.2019.01.006_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.micpath.2010.12.001","article-title":"Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model","volume":"50","author":"Saito","year":"2011","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jiac.2019.01.006_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/173.3.619","article-title":"Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure","volume":"173","author":"Stevens","year":"1996","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2008.01.008","article-title":"The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines","volume":"61","author":"Wang","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2169\/internalmedicine.42.211","article-title":"A\u00a0new therapeutic strategy for streptococcal toxic shock syndrome: a key target for cytokines","volume":"42","author":"Kawaguchi","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2019.01.006_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1471-4906(03)00079-6","article-title":"Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?","volume":"24","author":"Netea","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jiac.2019.01.006_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/171.1.74","article-title":"Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project","volume":"171","author":"Watanabe-Ohnishi","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2019.01.006_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial","volume":"43","author":"Madsen","year":"2017","journal-title":"Intensive Care Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:10Z","timestamp":1761159490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19300212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1341321X19300212"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.01.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Streptococcal toxic shock syndrome caused by \u03b2-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}